跳至主要内容
临床试验/JPRN-UMIN000002994
JPRN-UMIN000002994已完成未知

Phase I/II study of first line chemotherapy with TS-1 in elderly patients with advanced non-small cell lung cancer - Phase I/II study of first line chemotherapy with TS-1 in elderly patients with advanced non-small cell lung cancer

Kagawa TGO Study Group0 个研究点目标入组 45 人开始时间: 2010年1月7日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
45

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
75years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Serious medical complications 2)Patients with active lung disease such as interstitial pneumonia, pulmonary fibrosis 3)Massive pleural effusion,ascites and penicardial effusion requires drainage 4)Symptomatic brain metastasis 5)History of severe allergy 6)Received radiotherapy to primary region 7)Concomitant malignancy 8)Other clinical difficulties to this study

研究者

发起方
Kagawa TGO Study Group

相似试验

未知
1 期
A Phase I Study of Concurrent Chemotherapy using TS-1 with Involved Field Radiotherapy for Elderly Patients with Non-Small Cell Lung Cancer.on-Small Cell Lung Cancer
JPRN-UMIN000002162Hiroshima Radiation Oncology Study Group18
已完成
2 期
Phase II study of first line chemotherapy with UFT/LV in elderly patients with advanced/recurrent colorectal cancer.advanced/recurrent colorectal cancer
JPRN-UMIN000007138Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group30
进行中(未招募)
不适用
Phase II study of induction chemotherapy with TPF followed by radioimmunotherapy with Cetuximab and intensity modulated radiotherapy (IMRT) in combination with a carbon ion boost for locally advanced tumors of the oro- , hypopharynx and larynxTPF-C-HIT-Study - TPF-C-HITThe study is a phase II study of induction chemotherapy with docetaxel plus cisplatin and fluorouracil (TPF) followed by radioimmunotherapy with Cetuximab and intensity modulated radiotherapy (IMRT) in combination with a carbon ion boost for locally advanced tumors of the oro- , hypopharynx and laynx (TPF-C-HIT-Study)
EUCTR2009-016489-10-DEniversity of Heidelberg
已完成
不适用
Phase II study of neoadjuvant chemotherapy with the FEC followed by weekly nab-Paclitaxel(nanoparticle albumin-bound paclitaxel) for the operable breast cancer (KSCOG-BC07)Breast Cancer
JPRN-UMIN000010504Department of Surgery Kurume University School of Medicine30
已完成
1 期
Phase I/II study of induction chemotherapy with docetaxel,cisplatin and fluorouracil (DCF) followed by chemoradiotherapy in patients with unresectable locally advanced esophageal carcinoma.esophageal neoplasm
JPRN-UMIN000003370ational Cancer Center Hospital East30